(Q43962884)

English

Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress

scientific article published in March 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

chronic heart failure

1 reference

based on heuristic

inferred from title

Angus K. Nightingale

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Gethin R Ellis

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Daniel J Blackman

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Richard A Anderson

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Catherine Mumford

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Graham Timmins

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Derek Lang

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Simon K Jackson

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Michael D Penney

9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Malcolm J Lewis

10

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Michael P Frenneaux

11

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Jayne Morris-Thurgood

12

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

193-199

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Combined treatment with losartan and an ACE inhibitor in mild to moderate heart failure: results of a double-blind, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Neutrophil superoxide anion--generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Spin trapping: ESR parameters of spin adducts

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

The epidemiology of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Captopril in heart failure. A double blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Oxidative stress and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Angiotensin II-forming pathways in normal and failing human hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Radioimmunoassays of arginine vasopressin and atrial natriuretic peptide: application of a common protocol for plasma extraction using Sep-Pak C18 cartridges

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Lucigenin chemiluminescence in the assessment of neutrophil superoxide production

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Endothelial Control of Arterial Distensibility Is Impaired in Chronic Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Systolic time intervals in heart failure in man

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Enalapril reduces the catecholamine response to exercise in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Effects of ACE-inhibition on redox status and expression of P-selectin of endothelial cells subjected to oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

21 January 2018

Evidence against oxidative stress as mechanism of endothelial dysfunction in methionine loading model.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900002-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1388-9842(02)00002-8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43962884&oldid=2105063545"